Huntsman's Earnings and Revenues Lag Estimates in Q2, Down Y/Y — Negative

HUN   Zacks Investment Research — August 04, 2025

HUN posts wider-than-expected Q2 loss and lower revenues, hit by weak construction and industrial demand and reduced prices.

image for news Huntsman's Earnings and Revenues Lag Estimates in Q2, Down Y/Y

Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates — Negative

TWST   Zacks Investment Research — August 04, 2025

Twist Bioscience (TWST) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.86 per share a year ago.

image for news Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates

The premarket session on Monday has been somewhat positive in the US indices, as the markets are trying to recover from the massive selloff on Friday.

image for news NASDAQ Index, S&P 500 and Dow Jones Forecasts – US Indices Attempt to Recover Early on Monday

Warren Buffett's Berkshire Hathaway felt the sting of tariffs in the second quarter. First-half revenues slumped by around 39% at Jazwares, 12% at Fruit of the Loom, and 10% at Garan.

image for news Warren Buffett's Berkshire Hathaway is so big it's like a mini US economy. It just said where it's feeling the tariff pain.

Wall Street Still Doesn't Get PayPal And That's A Big Opportunity — Positive

PYPL   Seeking Alpha — August 04, 2025

PayPal remains deeply undervalued, trading at low valuation multiples despite solid growth and strong fundamentals, making it a compelling long-term investment opportunity. Recent Q2 results beat estimates and guidance was raised, but the market overreacted to short-term metrics like declining free cash flow and slower account growth. Buybacks are accelerating, reducing share count and boosting EPS, while initiatives like Buy Now, Pay Later and PayPal World offer significant future growth potential.

image for news Wall Street Still Doesn't Get PayPal And That's A Big Opportunity

Praxis (PRAX) Q2 Loss Widens 90% — Neutral

PRAX   The Motley Fool — August 04, 2025

Praxis (PRAX) Q2 Loss Widens 90%

image for news Praxis (PRAX) Q2 Loss Widens 90%

Cf Bankshares (CFBK) Q2 EPS Jumps 196% — Positive

CFBK   The Motley Fool — August 04, 2025

Cf Bankshares (CFBK) Q2 EPS Jumps 196%

image for news Cf Bankshares (CFBK) Q2 EPS Jumps 196%

Mural Oncology (MURA) Q2 Loss Widens 49% — Neutral

MURA   The Motley Fool — August 04, 2025

Mural Oncology (MURA) Q2 Loss Widens 49%

image for news Mural Oncology (MURA) Q2 Loss Widens 49%

Pfizer: Earnings Meet Pressure (Rating Upgrade) — Positive

PFE   Seeking Alpha — August 04, 2025

Pfizer's strong EPS surprise streak and positive earnings revisions are encouraging, but patent cliff risks remain a major concern for future growth. Valuation appears attractive with ratios below sector medians and Wall Street seeing significant upside, yet EPS stagnation tempers enthusiasm. Despite potential for another earnings beat, a miss could trigger a selloff, while the 7.3% dividend yield offers defensive appeal amid market uncertainty.

image for news Pfizer: Earnings Meet Pressure (Rating Upgrade)

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of HNI Corporation (NYSE: HNI) and Steelcase Inc. is fair to HNI shareholders. Upon closing of the proposed transaction, HNI shareholders will own approximately 64% of the combined company. Halper Sadeh encourages HNI shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalp.

image for news HNI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of HNI Corporation Is Fair to Shareholders

Order demonstrates the importance of Actelis' hybrid-fiber technology for carrier-grade enterprise applications, expanding the Company's footprint in the UK telecommunications market Order demonstrates the importance of Actelis' hybrid-fiber technology for carrier-grade enterprise applications, expanding the Company's footprint in the UK telecommunications market

image for news Actelis Networks Expands Its UK Presence With a Major Tier 2 Carrier Win for Enterprise Connectivity Solutions

Expect the S&P 500 to reach new all-time highs in August, says Fundstrat's Tom Lee — Positive

IVV  SPLG  SPXL  SPY  SSO  UPRO  VOO   CNBC Television — August 04, 2025

Tom Lee, Fundstrat co-founder and managing partner, Fundstrat Capital CIO and BitMine chairman, joins 'Squawk Box' to discuss the latest market trends, state of the economy, the Fed's inflation fight, latest developments at BitMine, and more.

image for news Expect the S&P 500 to reach new all-time highs in August, says Fundstrat's Tom Lee

5 High-Yield Monthly Pay Dividend Stocks Deliver Perfect Retirement Passive Income — Positive

AGNC  APLE  EPR  MAIN  O   24/7 Wall Street — August 04, 2025

Passive income is characterized by its ability to generate revenue without requiring the earner's continuous active effort, making it a desirable financial strategy for those seeking to diversify their income streams or achieve financial independence.

image for news 5 High-Yield Monthly Pay Dividend Stocks Deliver Perfect Retirement Passive Income

Reddit: The Bull Case Is Stronger Than Ever — Positive

RDDT   Seeking Alpha — August 04, 2025

Reddit's Q2 results smashed expectations, with revenue up 78% YoY and robust guidance for Q3, reinforcing my bullish thesis. I project Reddit can reach $5 billion EBIT by 2035, driven by user growth, deepening monetization, and disciplined cost management. Valuation modeling suggests Reddit's shares could compound at 11% annually, reaching $525-550 by 2035, offering strong long-term upside.

image for news Reddit: The Bull Case Is Stronger Than Ever

Options Corner: COIN Downgrade and Example Trade — Negative

COIN   Schwab Network — August 04, 2025

Coinbase (COIN) shares are down from all-time highs as investors react to its latest earnings report. Compass Point downgraded the stock to start the week.

image for news Options Corner: COIN Downgrade and Example Trade

Will This Small-Cap Nvidia Partner Surpass Earnings Expectations? — Neutral

NVTS   The Motley Fool — August 04, 2025

In today's video, I discuss recent updates affecting Navitas Semiconductor (NVTS 3.14%). To learn more, check out the short video, consider subscribing, and click the special offer link below.

image for news Will This Small-Cap Nvidia Partner Surpass Earnings Expectations?

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Steelcase Inc. (NYSE: SCS) to HNI Corporation for $7.20 in cash and 0.2192 shares of HNI common stock for each share of Steelcase is fair to Steelcase shareholders. Halper Sadeh encourages Steelcase shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

image for news SCS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Steelcase Inc. Is Fair to Shareholders

FORT WAYNE, Ind. , Aug. 4, 2025 /PRNewswire/ -- Indiana Michigan Power (I&M), an American Electric Power (Nasdaq: AEP) company, recently filed a special, joint contract with Google, designed to support I&M's capacity needs through clean generation and use of a Demand Response structure.

image for news I&M, Google Filing to Support Reliability Through Demand Response Structure

Interest Rates Heading Lower? 2 Picks To Not Loose Yield — Neutral

ADC  GPIQ   Seeking Alpha — August 04, 2025

The probability for having lower rates in 2025 is more than 50%. For yield investors this is not necessarily good news. The lower the rates, the higher the valuations, which might again lead to a yield-starved environment.

image for news Interest Rates Heading Lower? 2 Picks To Not Loose Yield

How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results? — Positive

ABBV   Zacks Investment Research — August 04, 2025

AbbVie's Q2 results show Skyrizi and Rinvoq powering growth, offsetting Humira declines and lifting 2025 sales outlook.

image for news How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?